Navigation Links
Minimum Acceptance Condition Satisfied
Date:2/17/2011

ucts and employees of Johnson & Johnson and Crucell as well as the ability to ensure continued performance or market growth of Crucell's products. A further list and description of these risks, uncertainties and other factors and the general risks associated with the respective businesses of Johnson & Johnson and Crucell can be found in Exhibit 99 of Johnson & Johnson's Annual Report on Form 10-K for the fiscal year ended 3 January 2010, and Crucell's Annual Report/ Form 20-F for the fiscal year ended 31 December 2009, as filed with the U.S. Securities and Exchange Commission on 7 April 2010, as well as other subsequent filings. Crucell prepares its financial statements under International Financial Reporting Standards (IFRS). Copies of these filings are available online at www.sec.gov, www.jnj.com, www.crucell.com or on request from Johnson & Johnson or Crucell. Neither Johnson & Johnson nor Crucell undertakes to update any forward-looking statements as a result of new information or future events or developments.)For further information please contact:Crucell N.V. - Media & InvestorsOya YavuzVice President Corporate Communications & Investor RelationsTel. +31 (0)71 519 7064ir@crucell.com www.crucell.com Johnson & Johnson – MediaKaren Manson

Bill PriceMob. + 32 479 89 47 99

Tel. +1 (732) 524 6623 Mob. +1 (732) 668 3735Johnson & Johnson – InvestorsLouise Mehrotra

Stan PanasewiczTel. +1 (732) 524 6491

Tel. +1 (732) 524 2524
'/>"/>

SOURCE Johnson & Johnson
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. NASDAQ Grants Insmed Incorporated 180-Day Extension to Regain Compliance with Minimum Bid Price Rule
2. NASDAQ Gives Dynatronics a Second Six-Month Extension for Minimum Bid Price Compliance
3. Poniard Pharmaceuticals Receives NASDAQ Deficiency Notice Related to Minimum Bid Price
4. Dynatronics Receives NASDAQ Minimum Bid Price Deficiency Letter
5. Catalyst Pharmaceutical Partners Regains Compliance with NASDAQ Minimum Bid Price Rule
6. Optimer Pharmaceuticals Announces FDA Acceptance of NDA for Filing and Designation of Priority Review for Fidaxomicin for the Treatment of Clostridium difficile Infection (CDI)
7. MHRA Issues Notice of Acceptance for Phase 3 Trial of GALNS for the Treatment of MPS IVA
8. Pacira Pharmaceuticals Announces FDA Acceptance of EXPAREL™ New Drug Application for Pain Management
9. MHRA Completes Review of CTA and Issues Notice of Acceptance for BMN 673 for Genetically-Defined Cancers
10. Accera, Inc. Appoints Dr. Thomas Werner President & CEO and Announces FDA Acceptance of IND Application for AC-1204 for Mild-to-Moderate Alzheimers Disease
11. Acuo Technologies Announces Implementation and Acceptance of Acuos DICOM Services Grid(TM) With Lancaster General Hospital
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... , Dec. 23, 2014  Advanced Medical ... company engaged primarily in the development of brachytherapy ... applications, today announced that it has filed a ... and Drug Administration ("FDA") for marketing clearance for ... 513(f)(2) of the U.S. Food, Drug and Cosmetic ...
(Date:12/24/2014)... 24, 2014 LifeScienceIndustryResearch.com ... Disposable Syringe Industry of 178 pages providing ... intelligence library. The 2014 Market ... is a professional and deep research report ... analysis, the report introduces Disposable Syringe basic ...
(Date:12/24/2014)... 2014   Assurex Health, a personalized medicine ... providers for behavioral health and chronic pain conditions, ... in equity financing from new and existing investors, ... and Chief Executive Officer. The financing ... Assurex Health,s GeneSight ®  products.  GeneSight,s ...
Breaking Medicine Technology:Advanced Medical Isotope Corporation Files a "de novo" Submission for Y-90 RadioGel(TM) Device 2Advanced Medical Isotope Corporation Files a "de novo" Submission for Y-90 RadioGel(TM) Device 3World Disposable Syringe Market 2014 Report: China and Regional Analysis 2World Disposable Syringe Market 2014 Report: China and Regional Analysis 3World Disposable Syringe Market 2014 Report: China and Regional Analysis 4World Disposable Syringe Market 2014 Report: China and Regional Analysis 5Assurex Health Secures $30 Million Financing Round to Continue Growth in Neuropsychiatric Pharmacogenomics 2Assurex Health Secures $30 Million Financing Round to Continue Growth in Neuropsychiatric Pharmacogenomics 3Assurex Health Secures $30 Million Financing Round to Continue Growth in Neuropsychiatric Pharmacogenomics 4
... WaferGen Biosystems, Inc. (OTC Bulletin Board: WGBS ), a ... will present an overview of the company at the 13th annual ... Waldorf Astoria Hotel, Tuesday, February 15, 2011 at 11:30 a.m. Eastern ... days and may be accessed at www.wafergen.com . ...
... Ill., Feb. 2, 2011 Hospira, Inc. (NYSE: ... company, today reported results for the fourth quarter and full ... 2010, net sales were $992 million, and adjusted* diluted earnings ... $3.9 billion, and adjusted* diluted earnings per share were $3.31. ...
Cached Medicine Technology:WaferGen to Present at 13th Annual BIO CEO and Investor Conference 2Hospira Reports Fourth-Quarter and Full-Year 2010 Results 2Hospira Reports Fourth-Quarter and Full-Year 2010 Results 3Hospira Reports Fourth-Quarter and Full-Year 2010 Results 4Hospira Reports Fourth-Quarter and Full-Year 2010 Results 5Hospira Reports Fourth-Quarter and Full-Year 2010 Results 6Hospira Reports Fourth-Quarter and Full-Year 2010 Results 7Hospira Reports Fourth-Quarter and Full-Year 2010 Results 8Hospira Reports Fourth-Quarter and Full-Year 2010 Results 9Hospira Reports Fourth-Quarter and Full-Year 2010 Results 10Hospira Reports Fourth-Quarter and Full-Year 2010 Results 11Hospira Reports Fourth-Quarter and Full-Year 2010 Results 12Hospira Reports Fourth-Quarter and Full-Year 2010 Results 13Hospira Reports Fourth-Quarter and Full-Year 2010 Results 14Hospira Reports Fourth-Quarter and Full-Year 2010 Results 15Hospira Reports Fourth-Quarter and Full-Year 2010 Results 16Hospira Reports Fourth-Quarter and Full-Year 2010 Results 17Hospira Reports Fourth-Quarter and Full-Year 2010 Results 18Hospira Reports Fourth-Quarter and Full-Year 2010 Results 19
(Date:12/25/2014)... Recently, BellasDress has launched its Christmas ... BellasDress has chosen their best-selling lace wedding dresses, vintage ... holiday season. , Now, BellasDress.com features popular women’s ... at discount prices. The business hopes everyone can have ... , “All our elegant products are made with ...
(Date:12/25/2014)... Helen Harris’ RP (Retinitis Pigmentosa) International ... after an 8 year battle with breast cancer. ... in her home in Woodland Hills California after an ... , As the founder and volunteer President ... and championed many of today's greatest breakthroughs in restoring ...
(Date:12/25/2014)... Recently, LunaDress.co.uk has updated its blog to provide professional ... all of the models at LunaDress.co.uk come with big discounts, up ... wedding veil can turn out to be a most exciting memory ... can always bring surprise to a wedding. On the updated fashion ... choose veils for a big day . , Going out with ...
(Date:12/25/2014)... The risk of burns from fires and cooking accidents ... extra cautious, an expert says. "Between Thanksgiving and ... patients coming in with burns," said Dr. Steven Sandoval, ... Center of Stony Brook University Hospital in New York. ... if not careful, could quickly turn tragic," Sandoval said ...
(Date:12/25/2014)... early stage breast cancer patients who undergo chemotherapy and/or ... eventually develop leukemia as a result of their treatment, ... a review of more than 20,000 breast cancer cases ... the risk for developing treatment-related leukemia, though low, is ... frequency of bone marrow cancers such as leukemia is ...
Breaking Medicine News(10 mins):Health News:BellasDress.com’s Christmas Sale: Trendy Wedding Dresses With Big Discounts 2Health News:RP International founder, Helen Harris Dies on Christmas Eve Just Hours Before Her Holiday Television Broadcast to Raise Funds to Cure Blindness was Broadcasted Nationally 2Health News:RP International founder, Helen Harris Dies on Christmas Eve Just Hours Before Her Holiday Television Broadcast to Raise Funds to Cure Blindness was Broadcasted Nationally 3Health News:RP International founder, Helen Harris Dies on Christmas Eve Just Hours Before Her Holiday Television Broadcast to Raise Funds to Cure Blindness was Broadcasted Nationally 4Health News:LunaDress Provides Professional Tips On Shopping Wedding And Prom Dresses 2Health News:Don't Let Burns Mar Your Holidays 2Health News:Breast Cancer Chemo Tied to Small But Significant Leukemia Risk 2Health News:Breast Cancer Chemo Tied to Small But Significant Leukemia Risk 3
... patterns and chronic obstructive pulmonary disease among men has ... developing progressive inflammatory lung disease (COPD). ,COPD ... chronic progressive lung disease, such as emphysema and bronchitis. ... almost 43,000 men, who were already part of the ...
... for the horizontally inclined. An American inventor has come ... and lose weight , while working at the computer. ... Minn., who designed the standup "walk-and-work" desk, suggest it ... what are traditionally sit-down tasks. The workstation can be ...
... flu vaccines to healthy adults in the age range of 5 ... . The U.S Food and Drug Administration is now ... 5 years. ,This announcement comes at a time when ... 15.6 billion dollars. AstraZeneca was behind MedImmune because it did ...
... anxiety appears to increase the risk of heart attacks and death ... artery disease is caused by plaque build-up on the inside walls ... This causes them to harden and narrow. This ... other serious complications. , According to a report in ...
... mentally less advanced than expected about 29 millions years ago, ... revealed. ,Elwyn Simons identified the second and the ... and subjected it to micro CT scanning to calculate the ... ,Based on previous fossils collected at the same dig ...
... cereals and of magnesium may each be associated with a ... and meta-analysis in the issue of Archives of Internal ... diagnosed with diabetes worldwide may increase from 171 million in ... in the article. The associated illness, death and health care ...
Cached Medicine News:Health News:Stand Up And Get Back To Work! 2Health News:Influenza Vaccine FluMist To Be Approved In Younger Children As Well 2Health News:Dont Worry- Be Good To Your Heart 2Health News:Risk of Diabetes is Reduced by Intake of Grain Fiber and Magnesium 2
... Hand Implant System utilizes the same proven ... replacements. The SR™ Hand Implant System ... prostheses including minimal bone resection, surface replacement ... surfaces, retention and/or repositioning of the ligamentous ...
For use in implant resection arthroplasty of the trapeziometacarpal joint in cases of rheumatoid, degenerative or post-traumatic arthritis....
The efficient choice for small joint replacement technology -- the Ascension Silicone MCP features a similar design to our PyroCarbon MCP and utilizes the same instrumentation for intra-operative fle...
... Hand Implant System utilizes the same proven ... replacements. The SR™ Hand Implant System ... prostheses including minimal bone resection, surface replacement ... surfaces, retention and/or repositioning of the ligamentous ...
Medicine Products: